Eli Lilly and Co (BSP:LILY34)
R$ 130.52 -2.2 (-1.66%) Market Cap: 3.72 Til Enterprise Value: 3.84 Til PE Ratio: 113.84 PB Ratio: 56.38 GF Score: 73/100

Eli Lilly and Co at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 05:10PM GMT
Release Date Price: R$47.29 (-1.53%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Thank you guys for joining us. Pleasure to have Dan from Lilly management, an R&D organization, join us. I feel like it's become a bit of an annual tradition and maybe Dan's the only one to raise his hand to agreeing to do this every year, but I apologize in advance, Dan.

Daniel M. Skovronsky
Eli Lilly and Company - Senior VP, Chief Scientific Officer & President of Lilly Research Labs

Thanks for that. I didn't know I [cursed you], Umer. I thought this was a part of my job.

Questions & Answers

Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Fantastic. Well, I feel like we should start today with a topic that you guys never get questions on, which is Alzheimer's. And maybe perhaps -- actually, even before that, Dan, let me turn it over to you first. Maybe lay out the top R&D priorities from your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot